We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Amylin Pharmaceuticals, Inc. (MM) | NASDAQ:AMLN | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 30.98 | 0 | 00:00:00 |
From Jan 2020 to Jan 2025
Bristol-Myers Squibb Co. (BMY) executive Robert Ramnarine has been arrested by the Federal Bureau of Investigation and charged with insider trading, Bloomberg News reported Thursday.
The FBI alleges that Ramnarine, executive director of pensions and savings, profited by buying options of companies whose pension plans he evaluated because they were Bristol-Myers acquisition candidates.
The FBI said he bought options in ZymoGenetics Inc., Pharmasset Inc. and Amylin Pharmaceuticals Inc. (AMLN).
Paul Fishman, U.S. Attorney for the District of New Jersey, said in a statement that Ramnarine will appear in federal court in Newark, N.J., Thursday, Bloomberg reported.
Full story at http://www.bloomberg.com/news/2012-08-02/bristol-myers-executive-ramnarine-charged-with-insider-trading.html
Write to nymonitoring@dowjones.com
Subscribe to WSJ: http://online.wsj.com?mod=djnwires
1 Year Amylin Pharmaceuticals, Inc. (MM) Chart |
1 Month Amylin Pharmaceuticals, Inc. (MM) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
